Morikawa K, Nakamura A, Shimazaki T, & Sakamoto N. (2018). Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: Current evidence. Dove Medical Press.
Chicago Style (17th ed.) CitationMorikawa K, Nakamura A, Shimazaki T, and Sakamoto N. Safety and Efficacy of Elbasvir/grazoprevir for the Treatment of Chronic Hepatitis C: Current Evidence. Dove Medical Press, 2018.
MLA (9th ed.) CitationMorikawa K, et al. Safety and Efficacy of Elbasvir/grazoprevir for the Treatment of Chronic Hepatitis C: Current Evidence. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.